nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Topotecan—ovarian cancer	0.101	0.354	CbGbCtD
Desvenlafaxine—CYP3A4—Vinorelbine—ovarian cancer	0.071	0.25	CbGbCtD
Desvenlafaxine—CYP3A4—Paclitaxel—ovarian cancer	0.0499	0.175	CbGbCtD
Desvenlafaxine—CYP3A4—Docetaxel—ovarian cancer	0.0361	0.127	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—ovarian cancer	0.0269	0.0945	CbGbCtD
Desvenlafaxine—Urethral disorder—Paclitaxel—ovarian cancer	0.00201	0.00281	CcSEcCtD
Desvenlafaxine—Weight increased—Docetaxel—ovarian cancer	0.00197	0.00276	CcSEcCtD
Desvenlafaxine—Weight decreased—Docetaxel—ovarian cancer	0.00196	0.00275	CcSEcCtD
Desvenlafaxine—Diarrhoea—Chlorambucil—ovarian cancer	0.00194	0.00272	CcSEcCtD
Desvenlafaxine—Paraesthesia—Vinorelbine—ovarian cancer	0.00194	0.00272	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00194	0.00271	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00192	0.00268	CcSEcCtD
Desvenlafaxine—Eye disorder—Paclitaxel—ovarian cancer	0.00191	0.00268	CcSEcCtD
Desvenlafaxine—Tinnitus—Paclitaxel—ovarian cancer	0.00191	0.00267	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00191	0.00267	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Paclitaxel—ovarian cancer	0.0019	0.00266	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Docetaxel—ovarian cancer	0.00189	0.00265	CcSEcCtD
Desvenlafaxine—Decreased appetite—Vinorelbine—ovarian cancer	0.00188	0.00263	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00187	0.00261	CcSEcCtD
Desvenlafaxine—Fatigue—Vinorelbine—ovarian cancer	0.00186	0.00261	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Topotecan—ovarian cancer	0.00186	0.00261	CcSEcCtD
Desvenlafaxine—Angiopathy—Paclitaxel—ovarian cancer	0.00186	0.0026	CcSEcCtD
Desvenlafaxine—Constipation—Vinorelbine—ovarian cancer	0.00185	0.00259	CcSEcCtD
Desvenlafaxine—Immune system disorder—Paclitaxel—ovarian cancer	0.00185	0.00259	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00185	0.00258	CcSEcCtD
Desvenlafaxine—Chills—Paclitaxel—ovarian cancer	0.00184	0.00257	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Melphalan—ovarian cancer	0.00182	0.00255	CcSEcCtD
Desvenlafaxine—Epistaxis—Docetaxel—ovarian cancer	0.00182	0.00255	CcSEcCtD
Desvenlafaxine—Asthenia—Topotecan—ovarian cancer	0.00181	0.00254	CcSEcCtD
Desvenlafaxine—Alopecia—Paclitaxel—ovarian cancer	0.00181	0.00253	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—ovarian cancer	0.00181	0.00253	CcSEcCtD
Desvenlafaxine—Vomiting—Chlorambucil—ovarian cancer	0.00181	0.00253	CcSEcCtD
Desvenlafaxine—Mental disorder—Paclitaxel—ovarian cancer	0.00179	0.00251	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—ovarian cancer	0.00179	0.00251	CcSEcCtD
Desvenlafaxine—Malnutrition—Paclitaxel—ovarian cancer	0.00178	0.0025	CcSEcCtD
Desvenlafaxine—Asthenia—Melphalan—ovarian cancer	0.00178	0.00249	CcSEcCtD
Desvenlafaxine—Tension—Paclitaxel—ovarian cancer	0.00175	0.00245	CcSEcCtD
Desvenlafaxine—Dysgeusia—Paclitaxel—ovarian cancer	0.00175	0.00244	CcSEcCtD
Desvenlafaxine—Nervousness—Paclitaxel—ovarian cancer	0.00173	0.00242	CcSEcCtD
Desvenlafaxine—Diarrhoea—Topotecan—ovarian cancer	0.00173	0.00242	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Docetaxel—ovarian cancer	0.00171	0.0024	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Docetaxel—ovarian cancer	0.00171	0.00239	CcSEcCtD
Desvenlafaxine—Urethral disorder—Docetaxel—ovarian cancer	0.0017	0.00238	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—ovarian cancer	0.0017	0.00238	CcSEcCtD
Desvenlafaxine—Diarrhoea—Melphalan—ovarian cancer	0.00169	0.00237	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00169	0.00237	CcSEcCtD
Desvenlafaxine—Nausea—Chlorambucil—ovarian cancer	0.00169	0.00236	CcSEcCtD
Desvenlafaxine—Vision blurred—Paclitaxel—ovarian cancer	0.00168	0.00235	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—ovarian cancer	0.00167	0.00234	CcSEcCtD
Desvenlafaxine—Dizziness—Topotecan—ovarian cancer	0.00167	0.00234	CcSEcCtD
Desvenlafaxine—Tremor—Paclitaxel—ovarian cancer	0.00167	0.00234	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00166	0.00232	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Docetaxel—ovarian cancer	0.00164	0.0023	CcSEcCtD
Desvenlafaxine—Angioedema—Paclitaxel—ovarian cancer	0.00163	0.00228	CcSEcCtD
Desvenlafaxine—Eye disorder—Docetaxel—ovarian cancer	0.00162	0.00227	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Docetaxel—ovarian cancer	0.00161	0.00226	CcSEcCtD
Desvenlafaxine—Vomiting—Topotecan—ovarian cancer	0.00161	0.00225	CcSEcCtD
Desvenlafaxine—Vertigo—Paclitaxel—ovarian cancer	0.0016	0.00224	CcSEcCtD
Desvenlafaxine—Syncope—Paclitaxel—ovarian cancer	0.0016	0.00224	CcSEcCtD
Desvenlafaxine—Rash—Topotecan—ovarian cancer	0.00159	0.00223	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00159	0.00223	CcSEcCtD
Desvenlafaxine—Dermatitis—Topotecan—ovarian cancer	0.00159	0.00223	CcSEcCtD
Desvenlafaxine—Headache—Topotecan—ovarian cancer	0.00158	0.00222	CcSEcCtD
Desvenlafaxine—Palpitations—Paclitaxel—ovarian cancer	0.00157	0.00221	CcSEcCtD
Desvenlafaxine—Angiopathy—Docetaxel—ovarian cancer	0.00157	0.0022	CcSEcCtD
Desvenlafaxine—Vomiting—Melphalan—ovarian cancer	0.00157	0.0022	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—ovarian cancer	0.00157	0.0022	CcSEcCtD
Desvenlafaxine—Immune system disorder—Docetaxel—ovarian cancer	0.00157	0.00219	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00157	0.00219	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00157	0.00219	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00156	0.00219	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—ovarian cancer	0.00156	0.00219	CcSEcCtD
Desvenlafaxine—Rash—Melphalan—ovarian cancer	0.00156	0.00219	CcSEcCtD
Desvenlafaxine—Dermatitis—Melphalan—ovarian cancer	0.00156	0.00218	CcSEcCtD
Desvenlafaxine—Chills—Docetaxel—ovarian cancer	0.00156	0.00218	CcSEcCtD
Desvenlafaxine—Asthenia—Vinorelbine—ovarian cancer	0.00155	0.00217	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00155	0.00216	CcSEcCtD
Desvenlafaxine—Convulsion—Paclitaxel—ovarian cancer	0.00154	0.00216	CcSEcCtD
Desvenlafaxine—Hypertension—Paclitaxel—ovarian cancer	0.00154	0.00215	CcSEcCtD
Desvenlafaxine—Alopecia—Docetaxel—ovarian cancer	0.00153	0.00215	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—ovarian cancer	0.00153	0.00214	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00152	0.00213	CcSEcCtD
Desvenlafaxine—Mental disorder—Docetaxel—ovarian cancer	0.00152	0.00213	CcSEcCtD
Desvenlafaxine—Anxiety—Paclitaxel—ovarian cancer	0.00151	0.00212	CcSEcCtD
Desvenlafaxine—Malnutrition—Docetaxel—ovarian cancer	0.00151	0.00212	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00151	0.00211	CcSEcCtD
Desvenlafaxine—Nausea—Topotecan—ovarian cancer	0.0015	0.0021	CcSEcCtD
Desvenlafaxine—Dry mouth—Paclitaxel—ovarian cancer	0.00148	0.00208	CcSEcCtD
Desvenlafaxine—Diarrhoea—Vinorelbine—ovarian cancer	0.00148	0.00207	CcSEcCtD
Desvenlafaxine—Dysgeusia—Docetaxel—ovarian cancer	0.00148	0.00207	CcSEcCtD
Desvenlafaxine—Venlafaxine—ABCB1—ovarian cancer	0.00148	1	CrCbGaD
Desvenlafaxine—Nausea—Melphalan—ovarian cancer	0.00147	0.00206	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00145	0.00202	CcSEcCtD
Desvenlafaxine—Shock—Paclitaxel—ovarian cancer	0.00143	0.002	CcSEcCtD
Desvenlafaxine—Dizziness—Vinorelbine—ovarian cancer	0.00143	0.002	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00143	0.002	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00143	0.002	CcSEcCtD
Desvenlafaxine—Tachycardia—Paclitaxel—ovarian cancer	0.00142	0.00199	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—ovarian cancer	0.00141	0.00198	CcSEcCtD
Desvenlafaxine—Skin disorder—Paclitaxel—ovarian cancer	0.00141	0.00198	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00141	0.00197	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00141	0.00197	CcSEcCtD
Desvenlafaxine—Vomiting—Vinorelbine—ovarian cancer	0.00137	0.00193	CcSEcCtD
Desvenlafaxine—Rash—Vinorelbine—ovarian cancer	0.00136	0.00191	CcSEcCtD
Desvenlafaxine—Dermatitis—Vinorelbine—ovarian cancer	0.00136	0.00191	CcSEcCtD
Desvenlafaxine—Headache—Vinorelbine—ovarian cancer	0.00135	0.0019	CcSEcCtD
Desvenlafaxine—Syncope—Docetaxel—ovarian cancer	0.00135	0.0019	CcSEcCtD
Desvenlafaxine—Palpitations—Docetaxel—ovarian cancer	0.00133	0.00187	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00133	0.00187	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—ovarian cancer	0.00133	0.00186	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—ovarian cancer	0.00133	0.00186	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—ovarian cancer	0.00132	0.00185	CcSEcCtD
Desvenlafaxine—Insomnia—Paclitaxel—ovarian cancer	0.00132	0.00184	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—ovarian cancer	0.00131	0.00183	CcSEcCtD
Desvenlafaxine—Paraesthesia—Paclitaxel—ovarian cancer	0.00131	0.00183	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—ovarian cancer	0.0013	0.00183	CcSEcCtD
Desvenlafaxine—Somnolence—Paclitaxel—ovarian cancer	0.00129	0.00181	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00129	0.00181	CcSEcCtD
Desvenlafaxine—Nausea—Vinorelbine—ovarian cancer	0.00128	0.0018	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00128	0.00179	CcSEcCtD
Desvenlafaxine—Decreased appetite—Paclitaxel—ovarian cancer	0.00126	0.00177	CcSEcCtD
Desvenlafaxine—Dry mouth—Docetaxel—ovarian cancer	0.00126	0.00176	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00126	0.00176	CcSEcCtD
Desvenlafaxine—Fatigue—Paclitaxel—ovarian cancer	0.00125	0.00176	CcSEcCtD
Desvenlafaxine—Constipation—Paclitaxel—ovarian cancer	0.00124	0.00174	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00124	0.00173	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—ovarian cancer	0.00123	0.00172	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—ovarian cancer	0.00123	0.00172	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—ovarian cancer	0.00122	0.00171	CcSEcCtD
Desvenlafaxine—Shock—Docetaxel—ovarian cancer	0.00121	0.0017	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—ovarian cancer	0.00121	0.00169	CcSEcCtD
Desvenlafaxine—Tachycardia—Docetaxel—ovarian cancer	0.0012	0.00169	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—ovarian cancer	0.0012	0.00168	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.0012	0.00167	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—ovarian cancer	0.00116	0.00162	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00115	0.00161	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—ovarian cancer	0.00115	0.00161	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—ovarian cancer	0.00114	0.00159	CcSEcCtD
Desvenlafaxine—Insomnia—Docetaxel—ovarian cancer	0.00112	0.00156	CcSEcCtD
Desvenlafaxine—Paraesthesia—Docetaxel—ovarian cancer	0.00111	0.00155	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—ovarian cancer	0.00111	0.00155	CcSEcCtD
Desvenlafaxine—Somnolence—Docetaxel—ovarian cancer	0.0011	0.00153	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—ovarian cancer	0.00109	0.00153	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—ovarian cancer	0.00109	0.00153	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—ovarian cancer	0.00109	0.00152	CcSEcCtD
Desvenlafaxine—Decreased appetite—Docetaxel—ovarian cancer	0.00107	0.0015	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00107	0.0015	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00107	0.0015	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00106	0.00149	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—ovarian cancer	0.00106	0.00149	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—ovarian cancer	0.00106	0.00149	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—ovarian cancer	0.00106	0.00148	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00105	0.00148	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—ovarian cancer	0.00105	0.00148	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—ovarian cancer	0.00105	0.00147	CcSEcCtD
Desvenlafaxine—Asthenia—Paclitaxel—ovarian cancer	0.00104	0.00146	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—ovarian cancer	0.00103	0.00145	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—ovarian cancer	0.00103	0.00144	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00102	0.00143	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—ovarian cancer	0.00102	0.00143	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—ovarian cancer	0.00101	0.00142	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—ovarian cancer	0.00101	0.00141	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00101	0.00141	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—ovarian cancer	0.001	0.0014	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—ovarian cancer	0.000998	0.0014	CcSEcCtD
Desvenlafaxine—Diarrhoea—Paclitaxel—ovarian cancer	0.000995	0.00139	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—ovarian cancer	0.00099	0.00139	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—ovarian cancer	0.000983	0.00138	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—ovarian cancer	0.000978	0.00137	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000976	0.00137	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—ovarian cancer	0.000972	0.00136	CcSEcCtD
Desvenlafaxine—Dizziness—Paclitaxel—ovarian cancer	0.000962	0.00135	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—ovarian cancer	0.00096	0.00134	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—ovarian cancer	0.000957	0.00134	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—ovarian cancer	0.000949	0.00133	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—ovarian cancer	0.000943	0.00132	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—ovarian cancer	0.000925	0.0013	CcSEcCtD
Desvenlafaxine—Vomiting—Paclitaxel—ovarian cancer	0.000925	0.0013	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—ovarian cancer	0.000923	0.00129	CcSEcCtD
Desvenlafaxine—Rash—Paclitaxel—ovarian cancer	0.000917	0.00128	CcSEcCtD
Desvenlafaxine—Dermatitis—Paclitaxel—ovarian cancer	0.000916	0.00128	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—ovarian cancer	0.000916	0.00128	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—ovarian cancer	0.000915	0.00128	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—ovarian cancer	0.000914	0.00128	CcSEcCtD
Desvenlafaxine—Headache—Paclitaxel—ovarian cancer	0.000911	0.00128	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—ovarian cancer	0.000908	0.00127	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—ovarian cancer	0.0009	0.00126	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—ovarian cancer	0.000896	0.00125	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—ovarian cancer	0.000889	0.00124	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—ovarian cancer	0.000885	0.00124	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—ovarian cancer	0.000883	0.00124	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—ovarian cancer	0.00088	0.00123	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—ovarian cancer	0.000864	0.00121	CcSEcCtD
Desvenlafaxine—Nausea—Paclitaxel—ovarian cancer	0.000864	0.00121	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000861	0.00121	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—ovarian cancer	0.000848	0.00119	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—ovarian cancer	0.000847	0.00119	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—ovarian cancer	0.000845	0.00118	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—ovarian cancer	0.000844	0.00118	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—ovarian cancer	0.000833	0.00117	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000829	0.00116	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—ovarian cancer	0.000818	0.00115	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—ovarian cancer	0.000817	0.00114	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—ovarian cancer	0.000816	0.00114	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—ovarian cancer	0.000815	0.00114	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—ovarian cancer	0.000814	0.00114	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—ovarian cancer	0.000812	0.00114	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—ovarian cancer	0.000808	0.00113	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000804	0.00113	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—ovarian cancer	0.0008	0.00112	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000797	0.00112	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—ovarian cancer	0.000785	0.0011	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—ovarian cancer	0.000784	0.0011	CcSEcCtD
Desvenlafaxine—Rash—Docetaxel—ovarian cancer	0.000777	0.00109	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—ovarian cancer	0.000777	0.00109	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—ovarian cancer	0.000772	0.00108	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—ovarian cancer	0.000757	0.00106	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000755	0.00106	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—ovarian cancer	0.000752	0.00105	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—ovarian cancer	0.000751	0.00105	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—ovarian cancer	0.000747	0.00105	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—ovarian cancer	0.000747	0.00105	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000744	0.00104	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—ovarian cancer	0.000739	0.00104	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—ovarian cancer	0.000732	0.00103	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—ovarian cancer	0.000723	0.00101	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000718	0.00101	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—ovarian cancer	0.000717	0.001	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—ovarian cancer	0.000711	0.000996	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—ovarian cancer	0.000696	0.000975	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—ovarian cancer	0.000691	0.000968	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—ovarian cancer	0.000684	0.000958	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—ovarian cancer	0.000669	0.000937	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000664	0.00093	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—ovarian cancer	0.000663	0.000929	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—ovarian cancer	0.000658	0.000921	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—ovarian cancer	0.000613	0.000858	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—ovarian cancer	0.000597	0.000836	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—ovarian cancer	0.000569	0.000797	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000567	0.000794	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—ovarian cancer	0.000552	0.000773	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—ovarian cancer	0.00055	0.00077	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—ovarian cancer	0.000529	0.00074	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—ovarian cancer	0.000526	0.000737	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—ovarian cancer	0.000524	0.000734	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—ovarian cancer	0.000524	0.000734	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—ovarian cancer	0.000521	0.00073	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—ovarian cancer	0.000509	0.000713	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—ovarian cancer	0.000494	0.000692	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—ovarian cancer	0.000489	0.000685	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—ovarian cancer	0.000485	0.000679	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—ovarian cancer	0.000485	0.000679	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—ovarian cancer	0.000482	0.000675	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—ovarian cancer	0.000457	0.00064	CcSEcCtD
